Vivosel - Manufacturing the Future of Medicine

    Biotechnology Innovation

    Manufacturing the Future of Medicine

    Vivosel is a biotechnology company specializing in translational biotechnology, transforming advanced research into clinical-grade gene and cell therapies. With over 40 clinical trials and a GMP-licensed facility at Teknopark Istanbul, we pioneer the manufacturing of CAR-T cells, engineered exosomes, and mesenchymal stem cells for therapeutic use.

    What Are MSCs?

    Mesenchymal stem cells (MSCs) are specialized cells that can be obtained from bone marrow, adipose tissue, umbilical cord, and other tissues, with the potential to differentiate into various cell types.

    Regenerative

    They can differentiate into muscle, bone, cartilage, and fat cells.

    Immunomodulatory

    They regulate the immune system and can reduce inflammation.

    Exosome Production

    Through extracellular vesicles, they carry growth factors, proteins, and genetic material, forming the basis of their therapeutic properties.

    Mesenchymal Stem Cells visualization

    Our Products

    GMP-certified cell therapy products derived from Wharton's Jelly, offering cell-free therapeutic approaches with advantages of safety, efficacy, and ease of application.

    MSC-V Vial

    MSC-V

    Wharton's Jelly MSC

    High-quality mesenchymal stem cells derived from umbilical cord Wharton's Jelly. Used in regenerative medicine for tissue repair, anti-aging treatments, and various therapeutic applications.

    Storage: ≤ -70°C (2 Years)≤ +4°C (10 Days)
    EXO-V Vial

    EXO-V

    Wharton's Jelly MSC-derived Exosome

    Exosomes derived from MSCs provide a cell-free therapeutic approach, carrying growth factors, proteins, and genetic material for targeted regenerative treatments.

    Storage: ≤ -70°C (2 Years)≤ +4°C (10 Days)

    Clinical Applications

    MSC therapy has shown effectiveness across a wide range of conditions, with several treatments already approved in various markets worldwide.

    ConditionClinical PhaseMarket Approval
    GVHDPhase IIIYes (US & global)
    Crohn's DiseasePhase IIIYes (EU & S. Korea)
    OsteoarthritisPhase IIIYes (S. Korea & Iran)
    ALSPhase IIYes (S. Korea)
    Spinal Cord InjuryPhase IIYes (Japan)
    Rheumatoid ArthritisPhase IIIn trials
    Vivosel GMP Facility at Istanbul Teknopark
    Our Facility

    GMP-Certified Manufacturing

    Located at Cube Incubation within Istanbul Teknopark, our state-of-the-art GMP facility enables the production of advanced cell and gene therapies meeting the highest international standards.

    GMP-licensed facility
    40+ clinical trials globally
    ISO-certified laboratories
    Proprietary cell processing

    Vivosel has extensive regulatory and clinical experience in Türkiye, USA, and Europe.

    Our Journey

    2022

    Founded at Boğaziçi University

    Established roots at the Center for Targeted Therapy Technologies at Boğaziçi University Kandilli Campus, bringing together leading scientists and biotechnology experts.

    2024

    GMP Facility at Istanbul Teknopark

    Opened a state-of-the-art GMP manufacturing facility to accelerate production of advanced cell and gene therapies.

    2025

    MSC/Exosome Program Launch

    Initiated a clinical program for innovative MSC/Exosome-based therapeutic approaches offering hope to patients with limited treatment options.

    Leadership

    Board of Directors

    Metin Kurtoğlu, M.D., Ph.D.

    Metin Kurtoğlu, M.D., Ph.D.

    Co-founder

    A third-generation physician with extensive medical experience, Metin completed his internal medicine training at Jackson Memorial Health/University of Miami and pursued medical oncology at the National Institute of Health. In 2016, he became Employee #1 at Cartesian Therapeutics, where he led the development of 5 ATMP products, including the world's first RNA-transfected CAR-T cell therapy for autoimmune disorders.

    Utku Ateş, M.D., Ph.D.

    Utku Ateş, M.D., Ph.D.

    Co-founder

    With over 25 years of academic and industry experience in stem cells, tissue engineering, and cellular therapies, Utku founded the Ege University Cord Blood Bank—pioneering stem cell banking in Türkiye. He has served as Türkiye's Tissue & Cells Representative at Council of Europe EDQM meetings for over 17 years, shaping international standards.

    Research

    Selected Publications

    Ann Clin Transl Neurol • 2025

    Durability of Response to B-Cell Maturation Antigen-Directed mRNA Cell Therapy in Myasthenia Gravis

    DOI: 10.1002/acn3.70167

    Lancet Neurol • 2023

    Safety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis

    DOI: 10.1016/S1474-4422(23)00194-1

    Leukemia • 2021

    Preclinical evaluation of CD8+ anti-BCMA mRNA CAR T cells for treatment of multiple myeloma

    DOI: 10.1038/s41375-020-0951-5

    Our Capabilities

    GMP Mesenchymal Stem Cells & Exosomes

    MSC platforms and engineered exosomes for regenerative medicine, hair loss, and anti-aging treatments.

    GMP Gene Editing Platforms

    End-to-end GMP process development for gene editing applications.

    GMP-Grade Cell Products

    High-quality cell lines and raw materials for clinical research.

    Quality Control Laboratory

    In-house QC for EMA and FDA-aligned standards.

    Learn More About Vivosel

    Visit the Vivosel website to explore our research, publications, and ongoing clinical collaborations.

    Visit Website